Perricone, Carlo
 Distribuzione geografica
Continente #
AS - Asia 4.290
NA - Nord America 4.283
EU - Europa 2.589
SA - Sud America 1.228
AF - Africa 93
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 3
Totale 12.494
Nazione #
US - Stati Uniti d'America 4.171
SG - Singapore 2.444
BR - Brasile 1.048
IE - Irlanda 1.042
IT - Italia 550
CN - Cina 541
HK - Hong Kong 516
RU - Federazione Russa 454
VN - Vietnam 387
DE - Germania 128
KR - Corea 117
GB - Regno Unito 82
SE - Svezia 78
AR - Argentina 64
FI - Finlandia 63
CA - Canada 48
ID - Indonesia 44
FR - Francia 39
IN - India 39
BD - Bangladesh 36
EC - Ecuador 35
MX - Messico 35
ZA - Sudafrica 35
JP - Giappone 30
UA - Ucraina 30
CO - Colombia 24
IQ - Iraq 24
PL - Polonia 24
TR - Turchia 22
NL - Olanda 21
UZ - Uzbekistan 20
PY - Paraguay 19
ES - Italia 18
AT - Austria 16
EG - Egitto 13
MA - Marocco 13
VE - Venezuela 11
PE - Perù 10
SA - Arabia Saudita 9
CH - Svizzera 8
JO - Giordania 7
PK - Pakistan 7
CL - Cile 6
PA - Panama 6
TN - Tunisia 6
BO - Bolivia 5
GR - Grecia 5
IL - Israele 5
LB - Libano 5
NP - Nepal 5
SN - Senegal 5
UY - Uruguay 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
AZ - Azerbaigian 4
BE - Belgio 4
DZ - Algeria 4
JM - Giamaica 4
MY - Malesia 4
PT - Portogallo 4
CR - Costa Rica 3
CZ - Repubblica Ceca 3
HN - Honduras 3
KZ - Kazakistan 3
RO - Romania 3
SV - El Salvador 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
XK - ???statistics.table.value.countryCode.XK??? 3
BG - Bulgaria 2
BH - Bahrain 2
CG - Congo 2
CI - Costa d'Avorio 2
DK - Danimarca 2
HU - Ungheria 2
KE - Kenya 2
LT - Lituania 2
LU - Lussemburgo 2
LV - Lettonia 2
ML - Mali 2
NG - Nigeria 2
OM - Oman 2
TW - Taiwan 2
AL - Albania 1
AO - Angola 1
BB - Barbados 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CU - Cuba 1
CV - Capo Verde 1
DM - Dominica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GN - Guinea 1
GP - Guadalupe 1
GY - Guiana 1
IR - Iran 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LY - Libia 1
Totale 12.479
Città #
Singapore 1.568
Dublin 1.037
Hong Kong 515
Chandler 402
Santa Clara 346
Boardman 330
Altamura 321
Moscow 286
Medford 280
Princeton 278
Lawrence 225
Ashburn 219
Los Angeles 198
Dong Ket 143
Columbus 122
San Mateo 120
Seoul 115
São Paulo 96
Andover 95
Ho Chi Minh City 79
New York 67
The Dalles 67
Wilmington 67
Perugia 55
Hanoi 51
Helsinki 49
Beijing 48
Dallas 46
Piscataway 39
San Paolo di Civitate 37
Falls Church 33
Munich 31
Rio de Janeiro 30
Tokyo 25
Belo Horizonte 24
Guangzhou 23
Brooklyn 22
Nuremberg 22
Warsaw 22
Brasília 21
Montreal 21
Johannesburg 20
Shanghai 19
Chicago 18
Des Moines 18
Norwalk 18
Bolzano 17
Porto Alegre 17
Redmond 17
San Francisco 17
Hefei 16
Boston 15
Curitiba 15
Tashkent 15
Campinas 14
Da Nang 14
Guayaquil 14
Bologna 13
Houston 13
Magelang 13
Phoenix 13
Quito 13
Rome 13
Salvador 13
Stockholm 13
Atlanta 12
Baghdad 12
Denver 12
Jakarta 12
Biên Hòa 11
Buenos Aires 11
London 11
Manchester 11
Toronto 11
Chennai 10
Goiânia 10
Asunción 9
Charlotte 9
Frankfurt am Main 9
Guarulhos 9
Haiphong 9
Lappeenranta 9
Mexico City 9
San Jose 9
Amsterdam 8
Aracaju 8
Milan 8
Ribeirão Preto 8
Shenyang 8
São Bernardo do Campo 8
Volta Redonda 8
Zhengzhou 8
Amman 7
Bắc Ninh 7
Duque de Caxias 7
Orem 7
Poplar 7
Saint Petersburg 7
Santo André 7
Araçatuba 6
Totale 8.257
Nome #
Treating lupus patients with antimalarials: analysis of safety profile in a single-center cohort 98
Pregnancy outcome in systemic lupus erythematosus patients: a monocentric cohort analysis 95
The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19 77
Effectiveness and safety of baricitinib in rheumatoid arthritis: a monocentric, longitudinal, real-life experience 77
Belimumab is Able to Induce a Significant Improvement of Joint Activity Status in Patients Diagnosed with Systemic Lupus Erythematosus: Results From a 12-Month Longitudinal Study 75
COVID-19 as part of the hyperferritinemic syndromes: the role of iron depletion therapy 74
Correspondence on a € Anti-inflammatory therapy for COVID-19 infection: The case for colchicine' 74
Intravenous immunoglobulins at the crossroad of autoimmunity and viral infections 73
Autoantibodies in inflammatory arthritis 72
The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts’ Consensus 72
Homocysteinylated alpha 1 antitrypsin as an antigenic target of autoantibodies in seronegative rheumatoid arthritis patients 72
Genetic diversity of Staphylococcus aureus influences disease phenotype of systemic lupus erythematosus 71
Altered expression of miR-142, miR-155, miR-499a and of their putative common target MDM2 in systemic lupus erythematosus 71
Late-Onset and Elderly Psoriatic Arthritis: Clinical Aspects and Management 70
TNFAIP3 gene polymorphisms in three common autoimmune diseases: Systemic lupus erythematosus, rheumatoid arthritis, and primary sjogren syndrome - association with disease susceptibility and clinical phenotypes in Italian patients 68
A polymorphism upstream MIR1279 gene is associated with pericarditis development in Systemic Lupus Erythematosus and contributes to definition of a genetic risk profile for this complication 68
One year in review 2020: comorbidities, diagnosis and treatment of primary Sjögren's syndrome 67
Influence of autoimmunity and inflammation on endothelial function and thrombosis in systemic lupus erythematosus patients 67
Caffeine intake influences disease activity and clinical phenotype in systemic lupus erythematosus patients 67
STAT4, TRAF3IP2, IL10, and HCP5 Polymorphisms in Sjögren's Syndrome: Association with Disease Susceptibility and Clinical Aspects 67
Salivary Gland Ultrasonography in Sjögren's Syndrome: A European Multicenter Reliability Exercise for the HarmonicSS Project 67
Tackling the autoimmune side in Spondyloarthritis: A systematic review 67
Peripheral Nervous System Involvement in Sjögren’s Syndrome: Analysis of a Cohort From the Italian Research Group on Sjögren’s Syndrome 67
Microbiota and arthritis: cause or consequence? 66
Antiphospholipid and Antinuclear Antibodies in Young Patients after Myocardial Revascularization Procedures 66
An update on pathogenesis of psoriatic arthritis and potential therapeutic targets 66
Combined semiquantitative nail-enthesis complex ultrasonography and capillaroscopy in psoriasis and psoriatic arthritis 66
Autoimmune/Inflammatory Syndrome Induced by Adjuvants and Sjogren's Syndrome 65
[Mosaic of Autoimmunity- the Novel Factors of Autoimmune Diseases Revisited] 65
Jaccoud's arthropathy in systemic lupus erythematosus: clinical, laboratory and ultrasonographic features 65
Contribution of Janus-Kinase/Signal Transduction Activator of Transcription Pathway in the Pathogenesis of Vasculitis: A Possible Treatment Target in the Upcoming Future 65
Vaccines, adjuvants and autoimmunity 64
Switching Between Biological Treatments in Psoriatic Arthritis: A Review of the Evidence 64
Joint involvement influences quality of life in systemic lupus erythematosus patients 64
JAK inhibitors and autoimmune rheumatic diseases 63
The differential response to anti IL-6 treatment in COVID-19: the genetic counterpart 63
Hypertension and SARS-CoV-2 infection: is inflammation the missing link? 63
'Autoimmunity cutting edge at the 21st century. Representation of the 9th international congress of autoimmunity, nice, France 2014' 63
Authors' reply: Human papillomavirus vaccine and primary ovarian failure 63
Autoimmune/inflammatory syndrome induced by adjuvants (Shoenfeld's syndrome) - An update 62
Frequency and clinical correlates of antiphospholipid antibodies arising in patients with SARS-CoV-2 infection: findings from a multicentre study on 122 cases 61
On chronic fatigue syndrome and nosological categories 61
Staphylococcus aureus nasal carriage and autoimmune diseases: From pathogenic mechanisms to disease susceptibility and phenotype 59
Immune checkpoint inhibitors-induced autoimmunity: The impact of gender 59
Usefulness of composite indices in the assessment of joint involvement in systemic lupus erythematosus patients: correlation with ultrasonographic score 59
Validation of a disease-specific health-related quality of life measure in adult Italian patients with systemic lupus erythematosus: LupusQoL-IT. 58
The facts and fictions of precision medicine in autoimmune diseases: is the machine learning approach the response? 58
The forefront of autoimmunity 57
Prolactin and natural killer cells: Evaluating the neuroendocrine-immune axis in women with primary infertility and recurrent spontaneous abortion 57
Autoimmune/inflammatory syndrome induced by adjuvants - A new diagnostic problem or the solution of a diagnostic riddle 57
IL-35: a new immunomodulator in autoimmune rheumatic diseases 57
A 23-Plex Cytokine/Chemokine Analysis Identifies TNFRII, MMP-8, and sIL-1RII as Potential Biomarkers for Systemic Sclerosis 56
Predictors of complete 24-month remission and flare in patients with polymyalgia rheumatica 56
Methotrexate improves endothelial function in early rheumatoid arthritis patients after 3 months of treatment 56
). MONITORING OF ANTI-TNF RESPONSE TO TREATMENT IN RHEUMATOID ARTHRITIS: A THREE JOINTS SIMPLIFIED ULTRASONOGRAPHIC STUDY 56
Sjögren's syndrome: one year in review 2022 55
Traditional and disease-related non-computed variables affect algorithms for cardiovascular risk estimation in Sjögren's syndrome and rheumatoid arthritis 55
Significance of anti-La/SSB antibodies in primary Sjögren's syndrome patients with combined positivity for anti-Ro/SSA and salivary gland biopsy 55
Being a rheumatologist and a patient with a rheumatic disease today: A perspective at the time of COVID-19 55
Downregulation of immunoglobulin-like transcript-4 (ILT4) in patients with psoriatic arthritis 55
Silicone implants and lymphoma: The role of inflammation 55
War and Peace at the Feto-Placental Front Line: Recurrent Spontaneous Abortion 55
Angiogenesis in rheumatoid arthritis: A disease specific process or a common response to chronic inflammation? 55
Porphyromonas gingivalis and rheumatoid arthritis 54
Diagnostic and clinical significance of Crohn's disease-specific pancreatic anti-GP2 and anti-CUZD1 antibodies 54
Musculoskeletal ultrasound in monitoring response to apremilast in psoriatic arthritis patients: results from a longitudinal study 54
The autoimmune side of hereditary angioedema: Insights on the pathogenesis 54
Cardiovascular Involvement in Sjögren's Syndrome 54
The 2014 ACR annual meeting: A bird's eye view of autoimmunity in 2015 53
Treatment with Gonadotropin Releasing Hormone Agonists in Systemic Lupus Erythematosus Patients Receiving Cyclophosphamide: A Long-term Follow-up Study 53
Ultrasound scoring systems affect the distribution of sialadenitis scores in Sjögren's syndrome: an inter-system reproducibility study 52
Colchicine, an anti-rheumatic agent, as a potential compound for the treatment of COVID-19 52
ADALIMUMAB AND POLYMYALGIA RHEUMATICA. CLINICAL REMISSION BUT PERSISTING HIGH LEVELS OF ESR: A CONTROVERSY 52
Up-regulation of autophagy by etanercept treatment results in TNF-induced apoptosis reduction in EA.hy926 endothelial cell line 52
Premature ovarian failure in patients affected by systemic lupus erythematosus: a cross-sectional study 52
A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1 52
Ultrasonographic and clinical assessment of peripheral enthesitis in patients with psoriatic arthritis, psoriasis, and fibromyalgia syndrome: The ULISSE study 51
Human leukocyte antigen (Hla) typing study identifies maternal dq2 susceptibility alleles among infertile women: Potential associations with autoimmunity and micronutrients 51
Cardiovascular risk in systemic autoimmune diseases 50
Erratum: Corrigendum to “Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) 2013: Unveiling the pathogenic, clinical and diagnostic aspects” (Journal of Autoimmunity (2013) 47 (1–16) (S0896841113001364) (10.1016/j.jaut.2013.10.004)) 50
['ASIA' - Autoimmune/inflammatory syndrome induced by adjuvants: even and odd] 50
An overview on the genetic of rheumatoid arthritis: A never-ending story 50
Restoration of peripheral blood natural killer and B cell levels in patients affected by rheumatoid and psoriatic arthritis during etanercept treatment 50
Peripheral blood natural killer cells and mild thyroid abnormalities in women with reproductive failure 50
Polymorphisms in STAT4, PTPN2, PSORS1C1 and TRAF3IP2 genes are associated with the response to TNF inhibitors in patients with rheumatoid arthritis 50
The hepatitis B vaccine and autoimmune/inflammatory syndrome induced by adjuvants: Relationship with Saccharomyces cerevisiae 49
Complement, infection, and autoimmunity 49
Porphyromonas gingivalis in the tongue biofilm is associated with clinical outcome in rheumatoid arthritis patients 49
Genetics, Epigenetics, and Gender Impact in Axial-Spondyloarthritis Susceptibility: An Update on Genetic Polymorphisms and Their Sex Related Associations 49
Rational approach to the prescription of anti-rheumatic drugs in rheumatoid arthritis: a product leaflet-based strategy in Italy 48
Alteration of Mitochondrial DNA Copy Number and Increased Expression Levels of Mitochondrial Dynamics-Related Genes in Sjögren’s Syndrome 48
Power Doppler ultrasound monitoring of response to anti-tumour necrosis factor alpha treatment in patients with rheumatoid arthritis 48
Neuropsychiatric manifestations associated with anti-endothelial cell antibodies in systemic lupus erythematosus 48
Pregnancy and autoimmunity: A common problem 48
Anti-mutated citrullinated vimentin antibodies in antiphospholipid syndrome: diagnostic value and relationship with clinical features 48
Innate Immune System at the Maternal–Fetal Interface: Mechanisms of Disease and Targets of Therapy in Pregnancy Syndromes 48
Anti-TNF treatment response in rheumatoid arthritis patients with moderate disease activity: A prospective observational multicentre study (MODERATE) 48
Acne indotta da micofenolato mofetile in pazienti affetti da Lupus Eritematoso Sistemico: uno studio retrospettivo 48
Erosive arthritis in systemic lupus erythematosus: not only Rhupus 48
Myocardial ischaemia, coronary atherosclerosis and pulmonary pressure elevation in antiphospholipid syndrome patients 47
Totale 5.939
Categoria #
all - tutte 81.243
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 81.243


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021263 0 0 0 0 0 1 4 94 16 1 4 143
2021/20221.070 0 97 1 4 24 13 15 210 11 26 336 333
2022/20232.636 302 599 35 86 136 169 6 60 1.143 4 79 17
2023/2024970 57 97 77 28 15 18 72 8 28 146 235 189
2024/20253.891 41 358 35 106 582 115 152 269 1.088 294 493 358
2025/20263.996 604 452 551 1.001 844 544 0 0 0 0 0 0
Totale 12.869